Financial Toxicity in Patients With Early-stage Breast Cancer
ConditionBreast Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorNational Cancer Institute, Naples
About this trial
Non-profit, multicenter, prospective, observational study. This study aims to evaluate whether the articulated treatment algorithm that is now possible for early-stage breast cancer patients does produce tangible changes of financial distress over the time and whether the determinants of financial distress change their relative weight over the time.
Eligibility criteria
Qualifiers
Signed informed consent form
Age > 18 years at the time of study entry
Histologically confirmed stage I-III invasive breast carcinoma before starting any systemic treatment.
Disqualifiers
Stage IV invasive breast carcinoma
Major cognitive dysfunction or psychiatric disorders
Any previous systemic treatment for the current breast cancer
Trial design
Treatments tested in this trial
- Questionnaires
Treatment groups
864 Participants
are divided into 8 treatment groups8
Treatment groupsSee each treatment group below.
Sponsors and collaborators
Source ClinicalTrials.gov